X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 58 filers reported holding X4 PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 5.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,706,000 | +77.3% | 997,719 | 0.0% | 0.53% | +109.5% |
| Q2 2022 | $962,000 | -44.9% | 997,719 | 0.0% | 0.25% | -40.9% |
| Q1 2022 | $1,746,000 | -47.9% | 997,719 | -31.9% | 0.43% | -58.1% |
| Q4 2021 | $3,353,000 | -61.9% | 1,464,099 | -12.0% | 1.02% | -44.8% |
| Q3 2021 | $8,805,000 | -5.9% | 1,664,540 | +15.7% | 1.85% | +10.0% |
| Q2 2021 | $9,353,000 | – | 1,438,899 | – | 1.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |